Logo image of ARD

Ardagh Group SA (ARD) Stock Fundamental Analysis

NYSE:ARD - New York Stock Exchange, Inc. - - Currency: USD

24.75  +0.63 (+2.61%)

After market: 24.72 -0.03 (-0.12%)

Fundamental Rating

2

Taking everything into account, ARD scores 2 out of 10 in our fundamental rating. ARD was compared to 24 industry peers in the Containers & Packaging industry. ARD may be in some trouble as it scores bad on both profitability and health. ARD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARD had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.05%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 6.03%
PM (TTM) -0.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

3

2. Health

2.1 Basic Checks

There is no outstanding debt for ARD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

ARD has an Altman-Z score of 0.62. This is a bad value and indicates that ARD is not financially healthy and even has some risk of bankruptcy.
ARD has a Debt/Equity ratio of -34.80. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -34.8
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 2.77 indicates that ARD has no problem at all paying its short term obligations.
A Quick Ratio of 2.30 indicates that ARD has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.3

More info and screens

4

3. Growth

3.1 Past

ARD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.39%.
Measured over the past years, ARD shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.97% on average per year.
The Revenue has grown by 9.39% in the past year. This is quite good.
The Revenue has been decreasing by -1.05% on average over the past years.
EPS 1Y (TTM)-5.39%
EPS 3Y-6.97%
EPS 5YN/A
EPS Q2Q%21.62%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y-7.83%
Revenue growth 5Y-1.05%
Sales Q2Q%16.69%

3.2 Future

ARD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.94% yearly.
The Revenue is expected to grow by 8.07% on average over the next years. This is quite good.
EPS Next Y9.94%
EPS Next 2Y14.94%
EPS Next 3Y16.76%
EPS Next 5Y17.94%
Revenue Next Year10.92%
Revenue Next 2Y8.75%
Revenue Next 3Y8.72%
Revenue Next 5Y8.07%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ARD Yearly Revenue VS EstimatesARD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ARD Yearly EPS VS EstimatesARD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

ARD is valuated correctly with a Price/Earnings ratio of 15.66.
Compared to an average S&P500 Price/Earnings ratio of 29.53, ARD is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.01, ARD is valued correctly.
The average S&P500 Price/Forward Earnings ratio is at 22.65. ARD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.66
Fwd PE 13.01
ARD Price Earnings VS Forward Price EarningsARD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.25
ARD Per share dataARD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200 300

4.3 Compensation for Growth

ARD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ARD's earnings are expected to grow with 16.76% in the coming years.
PEG (NY)1.58
PEG (5Y)N/A
EPS Next 2Y14.94%
EPS Next 3Y16.76%

More info and screens

3

5. Dividend

5.1 Amount

ARD has a Yearly Dividend Yield of 2.42%.
Compared to an average S&P500 Dividend Yield of 2.27, ARD has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.42%

5.2 History

On average, the dividend of ARD grows each year by 12.62%, which is quite nice.
ARD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)12.62%
Div Incr YearsN/A
Div Non Decr YearsN/A
ARD Yearly Dividends per shareARD Yearly Dividends per shareYearly Dividends per share 2017 2020 2021 0.5 1 1.5

5.3 Sustainability

ARD has negative earnings and hence a negative payout ratio. The dividend may be in danger.
ARD's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-2350%
EPS Next 2Y14.94%
EPS Next 3Y16.76%

More info and screens

Ardagh Group SA

NYSE:ARD (10/5/2021, 8:42:00 PM)

After market: 24.72 -0.03 (-0.12%)

24.75

+0.63 (+2.61%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)02-18 2022-02-18/bmo
Inst Owners0.01%
Inst Owner Change-1.2%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap461.83M
Analysts84
Price Target30.45 (23.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.42%
Yearly Dividend0.6
Dividend Growth(5Y)12.62%
DP-2350%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.66
Fwd PE 13.01
P/S 0.06
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.25
EPS(TTM)1.58
EY6.38%
EPS(NY)1.9
Fwd EY7.69%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS383.23
BVpS-14.15
TBVpSN/A
PEG (NY)1.58
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 6.03%
PM (TTM) -0.08%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity -34.8
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.3
Altman-Z 0.62
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.39%
EPS 3Y-6.97%
EPS 5YN/A
EPS Q2Q%21.62%
EPS Next Y9.94%
EPS Next 2Y14.94%
EPS Next 3Y16.76%
EPS Next 5Y17.94%
Revenue 1Y (TTM)9.39%
Revenue growth 3Y-7.83%
Revenue growth 5Y-1.05%
Sales Q2Q%16.69%
Revenue Next Year10.92%
Revenue Next 2Y8.75%
Revenue Next 3Y8.72%
Revenue Next 5Y8.07%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A